Garrett W Lindemann

US Patent:

7993907, Aug 9, 2011

Filed:

May 8, 2002

Appl. No.:

10/140680

Inventors:

Garrett W. Lindemann - Benicia CA, US
John Lipani - Fountain Hills AZ, US

Assignee:

Mowycal Lending, LLC - Big Horn WY

International Classification:

C12Q 1/68
C07H 21/04
C12M 1/34

US Classification:

4352872, 435 6, 536 231, 536 241

Abstract:

The present invention provides a biochip microarray, with multiple properties for use in identification of gene- and protein-induction or repression by drugs, the evaluation of efficacy and toxicity of any drug of choice, prediction of efficacy and toxicity of newly-discovered drugs, families of drugs or classes of drugs. Experimental information acquired from the biochip is inputted into a Drug-Gene-Protein-Biology (DGPB) database from which experimental data can be mined and analyzed based on the users preferences. A method for predicting the effect of a test composition for the treatment of a disease also is described. An animal model for the disease is selected. A biochip array for evaluating the effect of the test composition for the treatment of the disease is provided. The test composition is tested in the animal model to obtain a first set of biological markers representative of the effect of the test composition in the animal model. The biochip array generates a first set of data representative of the first set of biological markers.

US Patent:

20070036839, Feb 15, 2007

Filed:

Jul 20, 2006

Appl. No.:

11/490566

Inventors:

Jose Antonio Matji Tuduri - Madrid, ES
Antonio Gomez-Pamo - Madrid, ES
Jose Lebrero - Madrid, ES
Garrett Lindemann - Sheridan WY, US

International Classification:

A61K 31/715
A23K 1/165

US Classification:

424442000, 514054000

Abstract:

Phosphorylated glucomannans may be purified from naturally occurring sources and used as a supplement to poultry feeds for the benefit of poultry production.

US Patent:

20070036840, Feb 15, 2007

Filed:

Jul 20, 2006

Appl. No.:

11/490716

Inventors:

Jose Antonio Matji Tuduri - Madrid, ES
Antonio Gomez-Pamo - Madrid, ES
Jose Lebrero - Madrid, ES
Garrett Lindemann - Sheridan WY, US

International Classification:

A61K 31/715
A23K 1/165

US Classification:

424442000, 514054000

Abstract:

Phosphorylated glucomannans may be purified from naturally occurring sources and used as a supplement to swine feeds for the benefit of swine production.

US Patent:

20080171002, Jul 17, 2008

Filed:

Jul 20, 2007

Appl. No.:

11/781135

Inventors:

Jose Antonio Matji Tuduri - Madrid, ES
Antonio F. Guerrero Gomez-Pamo - Madrid, ES
Jose Luis Alonso Lebrero - Madrid, ES
Garrett Lindemann - Big Horn WY, US
Manuel Lopez Cabrera - Madrid, ES
Pedro Majano Rodriguez - Madrid, ES
Ricardo Moreno Otero - Madrid, ES
Diego Serrano Gomez - Madrid, ES
Angel Corbi Lopez - Madrid, ES
Samuel Martin Vilchez - Madrid, ES

Assignee:

GOURMETCEUTICALS, LLC - Big Horn WY

International Classification:

A61K 8/60
A61K 31/715
A61K 39/00
A61K 39/21
A61K 39/12
A61K 39/008
A61K 39/245
A61Q 1/00
A61Q 1/10
A61Q 19/00
A61Q 17/04
A61Q 9/00
A61Q 3/02
A61Q 1/06
A61P 37/02
A61K 39/29
A61K 39/02
A61K 39/108
A61K 39/04
A61K 39/395

US Classification:

424 59, 514 54, 4241841, 4242081, 4242041, 4242691, 4242301, 4242281, 4242181, 4242341, 4242591, 4242481, 4241331, 424 64, 424 61, 424 63, 424 65, 424 701

Abstract:

Phosphorylated glucomannan polysaccharide compositions are shown to effectively enhance healthy immune function. Dosage forms including pills, sprays, functional foods and cosmetics may achieve this benefit while being essentially free of storage protein from nongerminated seeds of

US Patent:

62355031, May 22, 2001

Filed:

Jun 21, 1999

Appl. No.:

9/337634

Inventors:

Garrett W. Lindemann - Benicia CA
Paula A. Schueler - Benicia CA

Assignee:

Roche Diagnostics Corporation - Indianapolis IN

International Classification:

C12P 1934

US Classification:

435 912

Abstract:

Improved methods for obtaining polynucleotides comprising sequences which differ between two populations of DNA or CDNA are provided. Improvements include reduction in the number of amplification cycles, use of a nuclease digestion step prior to amplification, a novel oligonucleotide adapter for the practice of the improved method, and novel methods for selective amplification of the desired unique fragments and selective degradation of fragments containing sequences common to both populations. Fragments of a sample population are amplified using a primer that endows the amplification products with resistance to nuclease degradation. Fragments of a control population are amplified using a primer that targets the amplification products for preferential degradation. Multiple cycles of hybridization, nuclease treatment and amplification are utilized to provide enrichment of fragments unique to the sample population. Such unique fragments may represent new or amplified sequences in the sample population, sequences that are differently arranged in the sample population compared to the control population, and sequences that are differentially expressed in a cDNA population.

US Patent:

59587385, Sep 28, 1999

Filed:

Mar 24, 1997

Appl. No.:

8/823111

Inventors:

Garrett W. Lindemann - Benicia CA
Paula A. Schueler - Benicia CA

Assignee:

Roche Diagnostics Corporation - Indianapolis IN

International Classification:

C12P 1934

US Classification:

435 912

Abstract:

Improved methods for obtaining polynucleotides comprising sequences which differ between two populations of DNA or cDNA are provided. Improvements include reduction in the number of amplification cycles, use of a nuclease digestion step prior to amplification, a novel oligonucleotide adapter for the practice of the improved method, and novel methods for selective amplification of the desired unique fragments and selective degradation of fragments containing sequences common to both populations. Fragments of a sample population are amplified using a primer that endows the amplification products with resistance to nuclease degradation. Fragments of a control population are amplified using a primer that targets the amplification products for preferential degradation. Multiple cycles of hybridization, nuclease treatment and amplification are utilized to provide enrichment of fragments unique to the sample population. Such unique fragments may represent new or amplified sequences in the sample population, sequences that are differently arranged in the sample population compared to the control population, and sequences that are differentially expressed in a cDNA population.

US Patent:

20220381697, Dec 1, 2022

Filed:

May 27, 2022

Appl. No.:

17/827268

Inventors:

- Lexington KY, US
Garrett W. Lindemann - Buffalo WY, US

International Classification:

G01N 21/65
G01N 15/14
G01J 3/44
G06T 7/30
G06V 20/69

Abstract:

A system for analyzing biological specimens by spectral imaging includes a biosensor comprising at least one graphene layer on a substrate and a memory in communication with a processor. The biosensor is configured to acquire a biological specimen sample. The memory and the processor are configured to conduct Raman spectroscopy to obtain spectral data for the sample, transmit the spectral data to a hub for direct or indirect transmission to one or more servers, perform multivariate analysis on the spectral data, and deliver a report based on the multivariate analysis of the spectral data.

US Patent:

20230017081, Jan 19, 2023

Filed:

Jul 13, 2022

Appl. No.:

17/864025

Inventors:

- Sheridan WY, US
Garrett W. Lindemann - Buffalo WY, US

International Classification:

G01N 33/543
G01N 33/569
G01N 21/65
G01N 27/02
G01N 27/414

Abstract:

An example biosensor includes a substrate, a graphene layer disposed on the substrate, and a binding site bonded to the graphene. The binding site includes an antibody configured to bind a SARS-CoV- spike glycoprotein.